🇺🇸 FDA

Company profile · Sponsor

Otsuka

Otsuka Novel Products GmbH

E976DE3 · EMA pharma EU
Pipeline
9
Drugs
0
Patents
0

Quick answer

Otsuka (E976DE3) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E976DE3
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (9)

Search pipeline →

  1. AVP-786 matching Placebo, AVP-786, AVP-786

    Otsuka

    Agitation in Patients With Dementia of the Alzheimer's Type

    phase 3 small molecule active

    1 trial

  2. AVP-786 matching placebo, AVP-786

    Otsuka

    Agitation in Patients With Dementia of the Alzheimer's Type

    phase 3 small molecule active

    1 trial

  3. JNT-517 Placebo, JNT-517, JNT-517

    Otsuka

    Phenylketonuria

    phase 3 small molecule active

    1 trial

  4. Jinarc 30 mg tablets, Tolvaptan, Jinarc 15 mg tablets, Samsca 7.5 mg tablets

    Otsuka

    Autosomal Recessive Polycystic Kidney Disease

    phase 3 small molecule active

    1 trial

  5. Tolvaptan

    Otsuka

    Autosomal Recessive Polycystic Kidney Disease

    phase 3 small molecule active

    1 trial

  6. Sibeprenlimab, Sibeprenlimab placebo

    Otsuka

    Treatment of Sjögren’s disease

    phase 2 small molecule active

    1 trial

  7. A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Function

    Otsuka

    Tuberculosis

    phase 1 other active

    1 trial

  8. A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults

    Otsuka

    Incomplete Response - Major Depressive Disorder (IR-MDD)

    phase 1 other active

    1 trial

  9. A phase 1 trial to evaluate the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of VIS171 in participants with autoimmune disease(s)

    Otsuka

    Systemic lupus erythematosus, Immune-mediated focal segmental glomerulosclerosis, Alopecia Areata

    phase 1 other active

    1 trial

Frequently asked questions

What is Otsuka?

Otsuka (E976DE3) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Otsuka sponsor?

We track 9 ClinicalTrials.gov-linked programs for Otsuka, including AVP-786 matching Placebo, AVP-786, AVP-786 and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Otsuka company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.